Results For "Pasi-A.-Jänne"

1 News Found

AstraZeneca’s FLAURA2 Phase III trial showed favourable trend in EGFR-mutated advanced lung cancer

Diagnostic Center | March 23, 2024

AstraZeneca’s FLAURA2 Phase III trial showed favourable trend in EGFR-mutated advanced lung cancer

Combination shows consistent benefit across prespecified post-progression outcomes

Latest Stories

IIHMR Start-ups inks MoU with BMCHRC & HCG Hospital

LVPEI raises awareness and funds for retinoblastoma treatment with WHITATHON Run

Supernova Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Dr. R. Ananthanarayanan CEO, Sajjan India

Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries

Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries

Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region

We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region

Vinod Paremal President & MD, Evonik, India Region

Packaging